Congenital abnormalities and clinical features associated with Wilms' tumour: A comprehensive study from a centre serving a large population

European Journal of Cancer

Volumn 43, Issue 9, 2007, Pages 1422-1429

  Ng, A ^a   Griffiths, A ^a   Cole, T ^b   Davison, V ^b   Griffiths, M ^b   Larkin, S ^b   Parkes, S E ^a   Mann, J R ^a   Grundy, R G ^c  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Congenital abnormalities; Consanguinity; Wilms' tumour

Indexed keywords

ANIRIDIA; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; CONGENITAL DISORDER; CONSANGUINITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA REPAIR; ETHNIC DIFFERENCE; FEMALE; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MARSHALL SMITH SYNDROME; MENTAL DEFICIENCY; MORBIDITY; NEPHROBLASTOMA; PAKISTAN; POPULATION RESEARCH; PRIORITY JOURNAL; SCHOOL CHILD; URINARY TRACT DISEASE;

ABNORMALITIES; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC TECHNIQUES; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; PEDIGREE; WILMS TUMOR;

EID: 34249897770     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.03.020     Document Type: Article

References (31)

1. Breslow N.E., and Beckwith J.B. Epidemiological features of Wilms' tumour: results of the National Wilms' tumour Study. J Natl Cancer Inst 68 (1982) 429-436
2. Miller R.W., Fraumeni J.F., and Manning M.D. Association of Wilms' tumour with Aniridia, hemihypertrophy and other congenital abnormalities. New Eng J Med 270 (1964) 922-927
3. Breslow N.E., Beckwith J.B., Ciol M., and Sharples K. Age distribution of Wilms' tumour: report from the National Wilms' tumour study. Cancer Res 48 (1988) 1653-1657
4. Breslow N.E., Norris R., Norkool P.A., et al., National Wilms Tumor Study Group. Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol 21 24 (2003) 4579-4585
5. Gessler M., Poustka A., Cavenee W., Neve R.L., Orkin S.H., and Bruns G.A. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343 6260 (1990) 774-778
6. Kreidberg J.A., Sariola H., Loring J.M., et al. WT-1 is required for early kidney development. Cell 74 4 (1993) 679-691
7. Little M., and Wells C. A clinical overview of WT1 gene mutations. Hum Mutat 9 3 (1997) 209-225
8. Wiedemann H.R. Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur J Pediatr 141 (1983) 129
9. Ward A. Beckwith-Wiedemann syndrome and Wilms' tumour. Mol Hum Reprod 3 2 (1997) 157-168
10. Grundy R.G., Pritchard J., Baraitser M., Risdon A., and Robards M. Perlman and Wiedemann-Beckwith syndromes: two distinct conditions associated with Wilms' tumour. Eur J Pediatr 151 12 (1992) 895-898
11. Hughes-Benzie R.M., Tolmie J.L., McNay M., and Patrick A. Simpson-Golabi-Behmel syndrome: disproportionate fetal overgrowth and elevated maternal serum alpha-fetoprotein. Prenat Diagn 14 4 (1994) 313-318
12. Leisenring W.M., Breslow N.E., Evans I.E., Beckwith J.B., Coppes M.J., and Grundy P. Increased birth weights of National Wilms' Tumor Study patients suggest growth factor excess. Cancer Res 54 17 (1994) 4680-4683
13. Birch J.M., Alston R.D., McNally R.J., et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20 34 (2001) 4621-4628
14. Reid S., Renwick A., Seal S., et al. Biallelic BRAC2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour. J Med Genet 42 (2005) 147-151
15. Hanks S., Coleman K., Reid S., et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 36 11 (2004) 1159-1161
16. Pastore G., Carli M., Lemerle J., et al. Epidemiological features of Wilms' tumour: results of studies by the International Society of Paediatric Oncology (SIOP). Med Pediatr Oncol 16 (1988) 7-11
17. Porteus M.H., Narkool P., Neuberg D., et al. Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 18 10 (2000) 2026-2031
18. Mann J.R., Dodd H.E., Draper G.J., et al. Congenital abnormalities in children with cancer and their relatives: results from a case-control study (IRESCC). Br J Cancer 68 (1993) 357-363
19. Altmann A.E., Halliday J.L., and Giles G.G. Associations between congenital malformations and childhood cancer. A register-based case-control study. Br J Cancer 78 9 (1998) 1244-1249
20. Pendergrass T. Congenital anomalies in children with Wilms' tumour - a new survey. Cancer 37 (1976) 403-409
21. Ogilvy-Stuart A.L., and Parsons A.C. Miller syndrome (postaxial acrofacial dysostosis): further evidence for autosomal recessive inheritance and expansion of the phenotype. J Med Genet 28 10 (1991) 695-700
22. Merks J.H.M., Caron H.N., and Hennekam R.C.M. High incidence of malformation syndromes in a series of 1073 children with cancer. Am J Hum Genet 134A (2005) 132-143
23. Lindsay S., Ireland M., O' Brien O., et al. Large scale deletions in the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome. J Med Genet 34 (1997) 480-483
24. Williams D.K., Carlton D.R., Green S.H., Pearman K., and Cole T.R.P. Marshall-Smith syndrome: the expanding phenotype. J Med Genet 34 (1997) 842-845
25. Scott R.H., Stiller C.A., Walker L., and Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet 43 (2006) 705-715
26. Bundey S., and Alam H. A 5-year prospective study of the health of children in different ethnic groups, with particular reference to the effect of inbreeding. Eur J Hum Genet 1 (1993) 206-219
27. Powell J.E., Kelly A.M., Parkes S.E., Cole T.R.P., and Mann J.R. Cancer and congenital abnormalities in Asian children: a population-based study from the West Midlands. Br J Cancer 72 (1995) 1563-1569
28. Felgenhauer J.L., Barce J.M., Benson R.L., Nan B., Olson J.M., and Breslow N.E. No excess of early onset cancer in family members of Wilms' tumour patients. Cancer 92 (2001) 1606-1612
29. Moutou C., Hochez J., Chompret A., et al. The French Wilms' tumour study: no clear evidence for cancer prone families. J Med Genet 31 6 (1994) 429-434
30. Rahman N., Abidi F., Ford D., et al. Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1. Hum Genet 103 (1998) 547-556
31. Little S.E., Hanks S.P., King-Underwood L., et al. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study. J Clin Oncol 22 20 (2004) 4140-4146